The instruction for medical use of Imupret® medicine the Trade name of Imupret® the International unlicensed name Is not present the Dosage form of the Tablet, coated Structure One tablet, coated, contains active agents: powder of a mallow of roots of 8 mg of a camomile of flowers of 6 mg of a horsetail of a grass of 10 mg of walnut of leaves of 12 mg of a yarrow of a grass of 4 mg of an oak of bark of 4 mg of a dandelion medicinal herbs of 4 mg excipients: kernel of tablets: lactoses monohydrate, starch corn, potato starch, stearic acid, glucose monohydrate, silicon dioxide colloidal anhydrous cover of tablets: calcium carbonate, castor oil, glucose syrup, sucrose, indigotin (E 132), starch corn, dextrin, wax montanic glycolic, K 25 povidone, K 30 povidone, silicon dioxide colloidal anhydrous, shellac, talc, titan dioxide (E 171). The description of the Tablet, coated, round biconvex with a smooth surface of light blue color Pharmacotherapeutic group Drugs for treatment of diseases of a throat. Antiseptic agents. The other drugs ATX R02AA20 Code Pharmacological Pharmacokinetics Drug Properties combined therefore carrying out kinetic researches is not possible. A pharmacodynamics Pharmacological properties are caused by biologically active agents which are a part of drug. Имупрет® possesses anti-inflammatory, antiseptic and immunostimulating with actions. Active components which are Ingredients: the camomile, a mallow and a horsetail promotes increase in activity of nonspecific factors of protection of an organism due to increase in activity of macrophages and granulocytes. These components also promote destruction of phagocytal microbes due to intensive formation of bactericidal metabolites of oxygen. Polysaccharides, essential oils and flavonoids of a camomile, a mallow and a yarrow reduce hypostasis of a mucous membrane of airways. Tannins of bark of an oak have antiviral activity. Indications - prevention and treatment of acute and chronic diseases of upper airways (tonsillitis, pharyngitis, laryngitis) - prevention of complications in respiratory viral infections and as addition to therapy with antibiotics in bacterial infections the Adults accept the Route of administration and doses In acute diseases on 2 tablets of 5-6 times a day. After disappearance of acute symptoms the Adults accept 2 tablets 3 times a day. After disappearance of acute symptoms it is necessary to continue treatment within not less than one week. Tablets are swallowed entirely, without chewing and washing down with a small amount of liquid. Side effects are possible: - digestive tract disorders - allergic reactions to drug components in the form of skin rash, an itching, a small tortoiseshell At the first signs of allergic reaction it is necessary to stop administration of drug of Imupret®. Contraindications - individual hypersensitivity to drug components - the known allergy to family of a thistle family - children's age up to 18 years Medicinal interactions the Combination with antibacterial medicines is possible and reasonable. Interactions with other medicines are unknown. The special instructions Imupret® contains glucose, sucrose and lactose. Patients with hereditary intolerance of a galactose, deficiency of lactase, malabsorption of a glucose/galactose, intolerance of fructose or insufficiency of invertase-isomaltase should not use drug. If symptoms do not disappear after 1 week of administration of drug, consult with the doctor. Use for patients with diabetes 1 tablet is equivalent to 0.02 grain units (GU). Pregnancy and the period of a lactation during pregnancy and feeding by a breast it is necessary to take the drug only on doctor's orders. Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms Drug does not affect ability to run transport and to perform work with potentially dangerous mechanisms. Overdose Cases of overdose are not known the Form of release and packing On 25 tablets, coated, in blister strip packaging from aluminum foil and a film from PVH/PVDH. On the 2nd blister strip packaging together with the instruction for medical use in the state and Russian languages place in a pack from cardboard. To Store storage conditions in the dry and protected from light place, at a temperature not over 30 ºС. To store out of children's reach! A period of storage 4 years not to apply after an expiration date Prescription status Without prescription the Producer Bionorika XIE, D-92308 of Noymarkt / Germany the Owner of the registration certificate Bionorika XIE, D-92308 of Noymarkt / Germany the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods) Representation Bionorica SE/Bionorik XIE / Almaty, Central post office, p.o. box No. 200, ph. of 250-93-99e-mail: info@bionorica.kz
Related Products
